Our webinar is online: Mass spectrometry toolkit for the characterisation of protein glycosylation
12th July 2016
Thank you for your interest in Quality Assistance webinar Mass spectrometry toolkit for the characterisation of protein glycosylation given on July 12th at 16.00 Brussels time (GMT +1).
Please find below links to the following:
Characterisation of the glycosylation of Humira® (Adalimumab) and Erbitux®(Cetuximab) by high resolution mass spectrometry
Due to their mode of production, therapeutic mAbs present diverse and heterogeneous glycosylations. Their analysis may require the use of orthogonal analytical techniques in order to fully characterise their nature and location. In this application note, the use of mass spectrometry as a powerful tool for Adalimumab and Cetuximab glycosylation characterisation is presented.
Authors: Eric Largy, Fabrice Cantais, Géry Van Vyncht, Arnaud Delobel
Characterisation of the glycosylation of Enbrel® (Etanercept) by high resolution mass spectrometry
Due to their mode of production, therapeutic glycoproteins present complex and heterogeneous glycosylations. Their analysis usually requires the use of many orthogonal analytical techniques in order to fully characterise their nature and location. In this application note, the use of mass spectrometry as a powerful tool for Etanercept glycosylation characterisation is presented.
Authors: Eric Largy, Fabrice Cantais, Géry Van Vyncht, Arnaud Delobel
Contact David Wyngaert, our Business Development Director, for any further question you may have on this topic: +32 71 53 47 81 or david.wyngaert@quality-assistance.be